Exenatide Inpatient Trial: A Randomized Controlled Pilot Trial on the Safety and Efficacy of Exenatide (Byetta®) Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes
Phase of Trial: Phase IV
Latest Information Update: 17 Oct 2016
At a glance
- Drugs Exenatide (Primary) ; Antihyperglycaemics; Insulin glargine
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- 07 Jun 2017 Biomarkers information updated
- 06 Oct 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
- 06 Oct 2016 Planned primary completion date changed from 1 Sep 2016 to 1 Sep 2017.